Matches in Nanopublications for { ?s ?p "[The concentration of thrombin-activatable fibrinolysis inhibitor was particularly higher in patients with small cell carcinoma compared to those with adenocarcinoma or squamous cell carcinoma, and in cancer patients that responded to chemotherapy compared to non-responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP211094.RAbLgMmj2wrD27PSh2whzk7eTezyZpUXM2zlq-58uxG9c130_assertion description "[The concentration of thrombin-activatable fibrinolysis inhibitor was particularly higher in patients with small cell carcinoma compared to those with adenocarcinoma or squamous cell carcinoma, and in cancer patients that responded to chemotherapy compared to non-responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211094.RAbLgMmj2wrD27PSh2whzk7eTezyZpUXM2zlq-58uxG9c130_provenance.
- NP475893.RAlNDsjcAxaInRiOY1m5Ttu_t4PPKJVtPNM2IwhY-73yM130_assertion description "[The concentration of thrombin-activatable fibrinolysis inhibitor was particularly higher in patients with small cell carcinoma compared to those with adenocarcinoma or squamous cell carcinoma, and in cancer patients that responded to chemotherapy compared to non-responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475893.RAlNDsjcAxaInRiOY1m5Ttu_t4PPKJVtPNM2IwhY-73yM130_provenance.
- NP684266.RAtgQ65ffMuMIifUmEzuDFSxnFx_dPZLeskEq22hiy24s130_assertion description "[The concentration of thrombin-activatable fibrinolysis inhibitor was particularly higher in patients with small cell carcinoma compared to those with adenocarcinoma or squamous cell carcinoma, and in cancer patients that responded to chemotherapy compared to non-responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684266.RAtgQ65ffMuMIifUmEzuDFSxnFx_dPZLeskEq22hiy24s130_provenance.
- NP901343.RATtYgK1E3Hvz_ygKoYad9nlBZ3xHQDasnS2yCONSyab4130_assertion description "[The concentration of thrombin-activatable fibrinolysis inhibitor was particularly higher in patients with small cell carcinoma compared to those with adenocarcinoma or squamous cell carcinoma, and in cancer patients that responded to chemotherapy compared to non-responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP901343.RATtYgK1E3Hvz_ygKoYad9nlBZ3xHQDasnS2yCONSyab4130_provenance.
- NP531870.RA78JjTHGHRdg3NEvdtfQGBK2fzLys0ZGtSkoMap-HlNk130_assertion description "[The concentration of thrombin-activatable fibrinolysis inhibitor was particularly higher in patients with small cell carcinoma compared to those with adenocarcinoma or squamous cell carcinoma, and in cancer patients that responded to chemotherapy compared to non-responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531870.RA78JjTHGHRdg3NEvdtfQGBK2fzLys0ZGtSkoMap-HlNk130_provenance.
- NP323619.RAhaeRxODar0pegi1ZsIy-s6oLsArQc7B_iwmXyTrNAhM130_assertion description "[The concentration of thrombin-activatable fibrinolysis inhibitor was particularly higher in patients with small cell carcinoma compared to those with adenocarcinoma or squamous cell carcinoma, and in cancer patients that responded to chemotherapy compared to non-responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323619.RAhaeRxODar0pegi1ZsIy-s6oLsArQc7B_iwmXyTrNAhM130_provenance.
- NP450250.RArfsnFMClagLL0Azhv0ql43BHerOQ55Weu53ZPlvoZ9w130_assertion description "[The concentration of thrombin-activatable fibrinolysis inhibitor was particularly higher in patients with small cell carcinoma compared to those with adenocarcinoma or squamous cell carcinoma, and in cancer patients that responded to chemotherapy compared to non-responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450250.RArfsnFMClagLL0Azhv0ql43BHerOQ55Weu53ZPlvoZ9w130_provenance.